 |
Video: Compound Annual Growth Rate (CAGR) Definition
|
 |
| Date |
Open |
High |
Low |
Close |
Volume |
| 07/31/2017 |
$1.60 |
$1.75 |
$1.60 |
$1.74 |
7.60K | | 08/01/2017 |
$1.60 |
$1.72 |
$1.60 |
$1.60 |
7.40K | | 08/02/2017 |
$1.59 |
$1.72 |
$1.57 |
$1.72 |
10.30K | | 08/03/2017 |
$1.61 |
$1.75 |
$1.61 |
$1.73 |
23.10K | | 08/04/2017 |
$1.60 |
$2.20 |
$1.60 |
$2.19 |
30.00K |
 |
| Kalobios Pharmaceuticals is a biopharmaceutical company focused on the development of monoclonal antibody therapeutics. Using Co.'s Humaneered® antibody technology, Co. has produced a portfolio of antibodies to treat medical conditions with a primary clinical focus on respiratory diseases and cancer. Co. has developed three monoclonal antibodies to the clinical development stage: KB004, which is a Humaneered® anti-EphA3 monoclonal antibody; KB003, which is a Humaneered® anti-granulocyte macrophage colony-stimulating factor monoclonal antibody; and KB001-A, which is a Humaneered® developed for the prevention and treatment of Pseudomonas aeruginosa infections. | |
 |

KBIO (KBIO) has the following price history information. Looking back at KBIO historical stock prices for the last five trading days, on July 31, 2017, KBIO opened at $1.60, traded as high as $1.75 and as low as $1.60, and closed at $1.74. Trading volume was a total of 7.60K shares. On August 01, 2017, KBIO opened at $1.60, traded as high as $1.72 and as low as $1.60, and closed at $1.60. Trading volume was a total of 7.40K shares. On August 02, 2017, KBIO opened at $1.59, traded as high as $1.72 and as low as $1.57, and closed at $1.72. Trading volume was a total of 10.30K shares. On August 03, 2017, KBIO opened at $1.61, traded as high as $1.75 and as low as $1.61, and closed at $1.73. Trading volume was a total of 23.10K shares. On August 04, 2017, KBIO opened at $1.60, traded as high as $2.20 and as low as $1.60, and closed at $2.19. Trading volume was a total of 30.00K shares.
KBIO Historical Stock Prices By Date:

Below, we examine the compound annual growth rate — CAGR for short — of an investment into KBIO shares, starting with a $10,000 purchase of KBIO, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
07/14/2016 |
|
| End date: |
08/04/2017 |
|
| Start price/share: |
$4.20 |
|
| End price/share: |
$2.19 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-47.86% |
|
| Average Annual Total Return: |
-45.98% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$5,213.96 |
|
| Years: |
1.06 |
|
|
 |
| Date |
Close |
| 07/31/2017 | $1.74 | | 08/01/2017 | $1.60 | | 08/02/2017 | $1.72 | | 08/03/2017 | $1.73 | | 08/04/2017 | $2.19 |
|
 |